Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genesis Fertility Center PCLBKK:GFC 42 EV-to-EBIT is 47.26 as of Aug. 29, 2026, which is 206% above its 10-year median of 15.46. GuruFocus rates BKK:GFC with a GF Score™ of 42/100 and a GF Value™ of ฿3.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Genesis Fertility Center PCL ranks worse than 87.08% on this metric.
The historical rank and industry rank for Genesis Fertility Center PCL's EV-to-EBIT or its related term are showing as below:
BKK:GFC'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.34 Med: 15.46 Max: 52.23
Current: 47.26
During the past 5 years, the highest EV-to-EBIT of Genesis Fertility Center PCL was 52.23. The lowest was 10.34. And the median was 15.46.
BKK:GFC's EV-to-EBIT is ranked worse than 87.08% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs BKK:GFC: 47.26
Genesis Fertility Center PCL (BKK:GFC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Genesis Fertility Center PCL's Enterprise Value for the quarter that ended in Jun. 2026 was ฿458.0 Mil.
Genesis Fertility Center PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿8.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genesis Fertility Center PCL EV-to-EBIT Related Terms
Genesis Fertility Center PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Genesis Fertility Center PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genesis Fertility Center PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genesis Fertility Center PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Genesis Fertility Center PCL's EV-to-EBIT falls into.
Genesis Fertility Center PCL's current Enterprise Value is ฿418.4 Mil.
Genesis Fertility Center PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿8.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genesis Fertility Center PCL (BKK:GFC) has a EV-to-EBIT of 47.26 as of Aug. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Genesis Fertility Center PCL and its competitors. This is 206% above median its historical median of 15.46. Over the past decade, Genesis Fertility Center PCL's EV-to-EBIT has ranged from 10.34 to 52.23. According to the industry distribution chart, Genesis Fertility Center PCL ranks #418 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 87.1%.
Is Genesis Fertility Center PCL's EV-to-EBIT too high?
Genesis Fertility Center PCL's current EV-to-EBIT of 47.26 is 206% above median its 10-year median of 15.46. Over the past 10 years, this metric has ranged from a low of 10.34 to a high of 52.23. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. Genesis Fertility Center PCL's value of 47.26 is 199.5% above this industry median. Based on the distribution chart, Genesis Fertility Center PCL ranks #418 out of 480 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Genesis Fertility Center PCL has a GF Score™ of 42/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genesis Fertility Center PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Genesis Fertility Center PCL ranks #418 out of 480 companies for EV-to-EBIT. This places Genesis Fertility Center PCL in the lower half of its industry. The industry median EV-to-EBIT is 15.78. Genesis Fertility Center PCL's value of 47.26 is 199.5% above this benchmark. Historically, Genesis Fertility Center PCL's own EV-to-EBIT has ranged from 10.34 to 52.23 over the past decade. While the company's 10-year median is 15.46 vs. the industry median of 15.78, Genesis Fertility Center PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genesis Fertility Center PCL's current EV-to-EBIT of 47.26 is 199.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Genesis Fertility Center PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genesis Fertility Center PCL's current EV-to-EBIT is 47.26, which is 206% above median its own 10-year median of 15.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genesis Fertility Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Genesis Fertility Center PCL (BKK:GFC) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.60, compared to a current price of ฿2.14 — trading 40.6% below its estimated fair value. The current EV-to-EBIT is 47.26, which is 206% above median its 10-year median of 15.46 and 199.5% above the Healthcare Providers & Services industry median of 15.78. Genesis Fertility Center PCL's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Genesis Fertility Center PCL (BKK:GFC), the current EV-to-EBIT is 47.26 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genesis Fertility Center PCL (BKK:GFC) Overvalued in 2026?
Based on GuruFocus' analysis, Genesis Fertility Center PCL stock appears to be undervalued.
The current stock price of ฿2.14 is trading 40.6% below its estimated GF Value™ of ฿3.60.
GuruFocus considers Genesis Fertility Center PCL to be Significantly Undervalued.
Key valuation signals for BKK:GFC:
EV-to-EBIT: 47.26 (206% above median its 10-year median of 15.46)
GF Value™: ฿3.60 vs. price of ฿2.14 (40.6% below fair value)
Industry Position: 199.5% above the Healthcare Providers & Services median (#418 of 480)
No single metric tells the full story. See the BKK:GFC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genesis Fertility Center PCL is engaged in providing treatment and counseling services to infertile people, chromosome analysis by NGS technique services and providing investment services in other businesses consulting and management services. It operates in single segment of providing treatment and counseling services to infertile people.
42GF Score
Get the complete analysis for BKK:GFC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:GFC has been successfully added to your 
